Gene: EIF4E3
Official Full Name: eukaryotic translation initiation factor 4E family member 3provided by HGNC
Gene Summary: EIF4E3 belongs to the EIF4E family of translational initiation factors that interact with the 5-prime cap structure of mRNA and recruit mRNA to the ribosome (Joshi et al., 2004 [PubMed 15153109]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27421 | EIF4E3 Knockout cell line (HCT 116) | Human | EIF4E3 | 1:2~1:4 | Negative | Online Inquiry |
KO27422 | EIF4E3 Knockout cell line (HEK293) | Human | EIF4E3 | 1:3~1:6 | Negative | Online Inquiry |
KO27423 | EIF4E3 Knockout cell line (A549) | Human | EIF4E3 | 1:3~1:4 | Negative | Online Inquiry |
EIF4E3 gene knockout cell lines are engineered cellular models lacking the eukaryotic translation initiation factor 4E-3 (EIF4E3), a crucial component involved in mRNA translation regulation. These cell lines serve as valuable tools for studying the roles of EIF4E3 in various cellular processes, including cell proliferation, differentiation, and stress response. By disrupting the EIF4E3 gene, researchers can elucidate its specific contributions to gene expression regulation and its potential implications in diseases such as cancer and neurodegenerative disorders.
The primary function of these knockout cell lines hinges on the absence of EIF4E3, which leads to altered translation profiles and downstream signaling pathways. This modification permits researchers to analyze the impact of EIF4E3 deletion on cellular behavior and metabolism, including shifts in protein synthesis dynamics and post-translational modifications. Utilizing these cell lines enables the study of EIF4E3's role in pathological contexts, thereby advancing our understanding of how translation initiation influences the onset and progression of various diseases.
The significance of EIF4E3 gene knockout cell lines extends into both basic research and clinical applications. In a research setting, these models facilitate the exploration of therapeutic targets for conditions associated with dysregulated translation. Clinically, they provide insights into the development of potential biomarkers and interventions that can improve patient outcomes for diseases where EIF4E3 plays a pivotal role.
What sets these cell lines apart from conventional models is their specificity and precision in gene editing. By leveraging CRISPR technology, our knockout cell lines demonstrate high efficiency in gene disruption, providing researchers with reliable and reproducible experimental systems. Compared to alternative methods, such as pharmacological inhibition or knockdown approaches, the complete knockout of EIF4E3 offers a more definitive insight into its functional roles.
For researchers and clinicians looking to deepen their understanding of translation control systems and their implications in health and disease, the EIF4E3 gene knockout cell lines represent an essential resource. Our commitment to quality and innovation in biological products is underscored by our expertise in gene editing technologies, ensuring that you receive state-of-the-art tools tailored for advanced research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.